 role hepat viru non-b chronic liver diseas contribut hepat viru liver diseas unknown caus chronic hepat exclus non-a non-b hepat antibodi hepat surfac antigen-neg patient spectrum chronic liver diseas antibodi viru marker hepat infect first-gener radioimmunoassay frequenc follow patient group transfusion-associ non-a non-b hepat non-transfusion-associ non-a non-b hepat hepat surfac antigen-neg hepatocellular carcinoma cryptogen cirrhosi autoimmun chronic liver diseas patient miscellan type chronic liver diseas healthi control non-transfusion-associ case histori intraven drug use occup exposur health worker antibodi viru case hepatocellular carcinoma japanes patient american patient evid hepat infect comparison subgroup serum sampl second-gener radioimmunoassay first-gener assay increas antibodi frequenc hepat substanti role transfusion-associ non-transfusion-associ non-a non-b hepat hepatocellular carcinoma japan limit role cryptogen cirrhosi role autoimmun chronic liver diseas applic sensit immunoassay frequenc antibodi seroposit subgroup rel distinct risk group like